Illumina (ILMN) and Thermo Fisher Scientific (TMO) both sell to drug developers and the labs that test patients, but they ...

Image source: The Motley Fool. Vice President, Investor Relations - Rafael Tejada Chairman and Chief Executive Officer - Marc ...

Thermo Fisher Scientific Inc. shows 6% organic growth, margin expansion, and rising FCF. Click for this TMO earnings update.

Shares of Thermo Fisher Scientific (TMO) gained on Wednesday after the life sciences company raised its full-year outlook, reporting better-than-expected financials for Q3 2026, thanks mainly to its ...

Thermo Fisher Scientific delivered strong Q3 results, with 6% organic growth, EPS and sales beats, and raised full-year ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 2026 results , with sales up 9.1% year on year to $12.14 billion.

Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to spotlight Waters Corporation and Thermo ...

TD Cowen raised its Thermo Fisher target from USD 675 to USD 760 on October 13, 2026. Thermo Fisher's third-quarter results ...

GAAP diluted EPS in the third quarter of 2026 was $4.64, 9% growth versus the third quarter of 2025. GAAP operating income ...

Thermo Fisher Scientific Inc. reported third-quarter 2026 results on October 21, 2026, with revenue up 9 percent to USD 12.14 ...

Thermo Fisher beat on both lines with adjusted operating margin widening 120 basis points to 24.5%. Updated full-year ...

Thermo Fisher Scientific reported higher profit and revenue in the latest quarter, boosted in part by new product launches. The scientific instruments company posted a third-quarter profit of $1.72 ...